(Q48593977)

13 February 2018

title

Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine (English)

1 reference

13 February 2018

1 reference

1 reference

Frey K

1

1 reference

13 February 2018

Kilbourn M

series ordinal

2

1 reference

13 February 2018

Robinson T

series ordinal

3

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 September 1997

1 reference

13 February 2018

European Journal of Pharmacology

published in

1 reference

13 February 2018

volume

334

1 reference

13 February 2018

issue

2-3

1 reference

13 February 2018

page(s)

273-279

1 reference

13 February 2018

Neurotransmitter transporters: recent progress

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Long-Term Changes in Dopaminergic Innervation of Caudate Nucleus After Continuous Amphetamine Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

A rapid and reversible change in dopamine transporters induced by methamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

A simple synthesis of [11C]dihydrotetrabenazine (DTBZ)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Striatal dopamine nerve terminal markers but not nigral cellularity are reduced in spinocerebellar ataxia type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Multiple system atrophy. Clinical aspects, pathophysiology, and treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

The neural basis of drug craving: an incentive-sensitization theory of addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Amphetamine: effects on catecholamine systems and behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Withdrawal of repeated cocaine decreases autoradlographic [3H]mazindol-labelling of dopamine transporter In rat nucleus aecumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

[3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901152-7

10.1016/S0014-2999(97)01152-7

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018